Tim Kirchmann is a global pharmaceutical executive with over 15 years of experience in market access, pricing, and health economics. Currently, Tim serves as the Oncology Pipeline Lead for International Market Access & Pricing at AbbVie, where they shape global access strategy and collaborate with various teams to ensure payer-ready development across oncology assets. Previously, Tim led the global access launch for epcoritamab and oversaw market access strategies for AbbVie’s glaucoma portfolio, and held key roles at Allergan and SKC, where they advised numerous pharmaceutical companies on access strategies. Throughout their career, Tim has demonstrated strong cross-functional leadership and a commitment to continuous learning through education at prestigious institutions such as Harvard Business School Online and Udacity. In addition to their professional achievements, Tim has dedicated over a decade to coaching athletic teams, emphasizing performance improvement and long-term development.
This person is not in any teams
This person is not in any offices